Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Capital Expenditures Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -11.41%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 9.65%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 61.83%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -63.39%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 14.32%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 21.73%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 12.30%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 15.01%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn -16.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.96%
Dec 31, 2025 49.17%
Sep 30, 2025 -76.48%
Jun 30, 2025 -89.12%
Mar 31, 2025 -20.47%
Dec 31, 2024 -63.73%
Sep 30, 2024 305.53%
Jun 30, 2024 58.22%
Mar 31, 2024 187.95%
Dec 31, 2023 253.19%
Sep 30, 2023 -50.90%
Jun 30, 2023 16.97%
Mar 31, 2023 -52.44%
Dec 31, 2022 -34.36%
Sep 30, 2022 -7.92%
Jun 30, 2022 114.56%
Mar 31, 2022 211.92%
Dec 31, 2021 459.38%
Sep 30, 2021 -14.89%
Jun 30, 2021 -27.21%
Mar 31, 2021 -37.34%
Dec 31, 2020 -85.39%
Sep 30, 2020 58.87%
Jun 30, 2020 1.07%
Mar 31, 2020 68.53%
Dec 31, 2019 361.05%
Sep 30, 2019 38.13%
Jun 30, 2019 98.58%
Mar 31, 2019 -70.99%
Dec 31, 2018 -55.40%
Sep 30, 2018 7.08%
Jun 30, 2018 -41.00%
Mar 31, 2018 148.99%
Dec 31, 2017 109.01%
Sep 30, 2017 -81.85%
Jun 30, 2017 139.64%
Mar 31, 2017 -1.49%
Dec 31, 2016 55.02%
Sep 30, 2016 100.91%
Jun 30, 2016 -122.47%
Mar 31, 2016 119.25%
Dec 31, 2015 -573.24%
Sep 30, 2015 237.08%
Jun 30, 2015 680.95%
Mar 31, 2015 -270.21%
Dec 31, 2014 -46.53%
Sep 30, 2014 4.76%
Jun 30, 2014 -100.00%
Mar 31, 2014 20.34%
Dec 31, 2013 13.75%
Sep 30, 2013 6.84%
Jun 30, 2013 26.20%
Mar 31, 2013 -19.19%
Dec 31, 2012 -74.58%
Sep 30, 2012 -89.16%
Jun 30, 2012 25.83%
Mar 31, 2012 33.11%
Dec 31, 2011 -54.59%
Sep 30, 2011 -55.43%